R&D-Center has unique devices and equipment, which will allow to tackle tasks connected with modifying the pharmacological properties of drug products. Most of the technologies used have no analogues in the Russian pharmaceutical industry.
In addition to research, production and laboratory capabilities of the R&D-Center allow to scale up technological processes, to transfer technologies, to produce samples for clinical trials and also to produce small-scale batches. Read more about the services of the R&D-Center – read more here.
PILOT PRODUCTION |
R&D LABORATORY |
ANALYTICAL LABORATORY |
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024